(Q28295362)

English

Mortality in treated heterozygous familial hypercholesterolaemia: implications for clinical management. Scientific Steering Committee on behalf of the Simon Broome Register Group

scientific article

In more languages

Statements

scholarly article

0 references

Mortality in treated heterozygous familial hypercholesterolaemia: implications for clinical management. Scientific Steering Committee on behalf of the Simon Broome Register Group (English)

0 references

hypercholesterolemia

0 references

1 reference

based on heuristic

inferred from title

language of work or name

0 references

publication date

January 1999

0 references

Atherosclerosis

0 references

142

0 references

1

0 references

105-12

0 references

Risk of fatal coronary heart disease in familial hypercholesterolaemia. Scientific Steering Committee on behalf of the Simon Broome Register Group

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900200-7

7 January 2021

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900200-7

7 January 2021

Evidence-based management of dyslipidaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900200-7

7 January 2021

The Sheffield table for primary prevention of coronary heart disease: corrected

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900200-7

7 January 2021

Cardiovascular disease risk profiles.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900200-7

7 January 2021

Cohort study analysis with a FORTRAN computer program.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900200-7

7 January 2021

Coronary Disease in Familial Hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900200-7

7 January 2021

Family similarities in the age at coronary death in familial hypercholesterolaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900200-7

7 January 2021

Comparison of the effect of two low-density lipoprotein receptor class mutations on coronary heart disease among French-Canadian patients heterozygous for familial hypercholesterolaemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900200-7

7 January 2021

Influence of specific mutations at the LDL-receptor gene locus on the response to simvastatin therapy in Afrikaner patients with heterozygous familial hypercholesterolaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900200-7

7 January 2021

Familial hypercholesterolemia and apolipoprotein E4

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900200-7

7 January 2021

Relation of serum lipoprotein(a) concentration and apolipoprotein(a) phenotype to coronary heart disease in patients with familial hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900200-7

7 January 2021

Genetic and environmental factors affecting the incidence of coronary artery disease in heterozygous familial hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900200-7

7 January 2021

Ischaemic disease in men and women with familial hypercholesterolaemia and xanthomatosis. A comparative study of genetic and environmental factors in 274 heterozygous cases

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900200-7

7 January 2021

Plasma high-density lipoproteins and ischemic heart disease: studies in a large kindred with familial hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900200-7

7 January 2021

Plasma triglycerides related decrease in high-density lipoprotein cholesterol and its association with myocardial infarction in heterozygous familial hypercholesterolemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900200-7

7 January 2021

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900200-7

7 January 2021

Risks of ischaemic heart-disease in familial hyperlipoproteinaemic states

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900200-7

7 January 2021

Coronary artery disease in 116 kindred with familial type II hyperlipoproteinemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900200-7

7 January 2021

Cholesterol and heart disease in older persons and women. Review of an NHLBI workshop

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900200-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Coronary event and case fatality rates in an English population: results of the Oxford myocardial infarction incidence study. The Oxford Myocardial Infarction Incidence Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900200-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0021-9150(98)00200-7

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28295362&oldid=2042890847"